rs766903358
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014838.3(ZBED4):c.89A>G(p.Asp30Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000685 in 1,460,244 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014838.3 missense
Scores
Clinical Significance
Conservation
Publications
- ALG12-congenital disorder of glycosylationInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, G2P, ClinGen, Labcorp Genetics (formerly Invitae), PanelApp Australia, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZBED4 | ENST00000216268.6 | c.89A>G | p.Asp30Gly | missense_variant | Exon 2 of 2 | 1 | NM_014838.3 | ENSP00000216268.4 | ||
ZBED4 | ENST00000850559.1 | c.89A>G | p.Asp30Gly | missense_variant | Exon 2 of 2 | ENSP00000520851.1 | ||||
ZBED4 | ENST00000850560.1 | n.260+273A>G | intron_variant | Intron 2 of 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000797 AC: 2AN: 250994 AF XY: 0.00000737 show subpopulations
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1460244Hom.: 0 Cov.: 29 AF XY: 0.00 AC XY: 0AN XY: 726132 show subpopulations
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.89A>G (p.D30G) alteration is located in exon 2 (coding exon 1) of the ZBED4 gene. This alteration results from a A to G substitution at nucleotide position 89, causing the aspartic acid (D) at amino acid position 30 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at